Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Sales | 45,190 | 33,100 | 24,113 | 27,385 | 23,192 |
| Cost of Goods | 5,000 | 0 | 1,110 | 0 | 0 |
| Gross Profit | 40,190 | 33,100 | 22,990 | 27,385 | 23,192 |
| Operating Expenses | 45,880 | 40,541 | 40,336 | 48,765 | 52,444 |
| Operating Income | -5,690 | -7,441 | -17,223 | -21,380 | -29,252 |
| Interest Expense | 420 | 734 | 939 | 1,205 | 1,403 |
| Other Income | -2,510 | -3,403 | -14,261 | -922 | 0 |
| Pre-tax Income | -8,620 | -11,578 | -32,423 | -23,507 | -30,655 |
| Net Income Continuous | -8,625 | -11,579 | -32,424 | -22,915 | -30,655 |
| Net Income | $-8,620 | $-11,578 | $-32,423 | $-23,507 | $-30,655 |
| EPS Basic Total Ops | -0.28 | -0.40 | -1.33 | -1.19 | -1.62 |
| EPS Basic Continuous Ops | -0.28 | -0.40 | -1.33 | -1.16 | -1.62 |
| EPS Diluted Total Ops | -0.28 | -0.40 | -1.33 | -1.19 | -1.62 |
| EPS Diluted Continuous Ops | -0.28 | -0.40 | -1.33 | -1.16 | -1.62 |
| EBITDA(a) | $-2,680 | $-3,052 | $-11,143 | $-15,525 | $-25,157 |